Antimicrobial Agents and Chemotherapy · 2021 · 17 citations · 23 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceMedical MicrobiologyMycologyAntifungal AgentsAntifungal ResistanceAntifungal TherapyAntimicrobial Susceptibility TestingFungal DiagnosticsFungal InfectionsAntifungal Susceptibility TestingCandida DetectionClinical Laboratory EvaluationFluconazole TherapyFungal DetectionFungal Drug ResistanceFungal Pathogen DetectionResistance Breakpoint Determination
Susceptibility testing is an important tool in the clinical setting; its utility is based on the availability of categorical endpoints, breakpoints (BPs), or epidemiological cutoff values (ECVs/ECOFFs). CLSI and EUCAST have developed antifungal susceptibility testing, BPs, and ECVs for some fungal species.
23
Thomas F. Patterson, George R. Thompson, David W. Denning et al. · Clinical Infectious Diseases · 2016 · 2.8K citations · Full text
Veterinary Medicine, Infectious Diseases, Internal Medicine +17
Sofía Perea, José L. López-Ribot, William R. Kirkpatrick et al. · Antimicrobial Agents and Chemotherapy · 2001 · 471 citations · Full text